z-logo
Premium
Immature platelet fraction measured on the S ysmex XN hemocytometer predicts thrombopoietic recovery after autologous stem cell transplantation
Author(s) -
Linden Noreen,
Klinkenberg Lieke J.J.,
Meex Steven J.R.,
Beckers Erik A.M.,
Wit Norbert C.J.,
Prinzen Lenneke
Publication year - 2014
Publication title -
european journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.904
H-Index - 84
eISSN - 1600-0609
pISSN - 0902-4441
DOI - 10.1111/ejh.12319
Subject(s) - hemocytometer , stem cell , transplantation , platelet , andrology , immunology , medicine , chemistry , biology , microbiology and biotechnology , pathology
Objectives A period of thrombocytopenia is common after stem cell transplantation ( SCT ). To prevent serious bleeding complications, prophylactic platelet transfusions are administered. Previous studies have shown that a rise in immature platelets precedes recovery of platelet count. Our aim was to define a cutoff value for immature platelets predicting thrombopoietic recovery within 2 d. Methods Hematological parameters were measured on the S ysmex XN hemocytometer. We calculated reference change values ( RCV ) for platelets in eight healthy individuals as marker for platelet recovery. To define a cutoff value, we performed ROC analysis using data from 16 autologous SCT patients. Results RCV for platelet concentration was 14.1%. Platelet recovery was observed 13 (median; range 9–31) days after SCT . Increase in immature platelet fraction (IPF) before platelet recovery was seen in all autologous SCT patients. Optimal cutoff IPF was found to be 5.3% for platelet recovery within 2 d (specificity 0.98, sensitivity 0.47, positive predictive value 0.93). Conclusions We identified an optimal cutoff value for IPF 5.3% to predict platelet recovery after autologous SCT within 2 d. Implementing this cutoff value in transfusion strategy may reduce the number of prophylactic platelet transfusions.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here